Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time
13 févr. 2020 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Rev up your Valentine’s Day with this list of aphrodisiac foods from the 123Diet!
10 févr. 2020 12h52 HE
|
123 Diet
Boca Raton, FL, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Health expert Emma Taylor, whose 123Diet is an Australian sensation, is here to help you have the Valentine’s Day of your dreams. As someone who’s...
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund
07 févr. 2020 16h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon Enters into a Distribution Agreement for Qatar
18 déc. 2019 08h30 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable,...
123Diet Inspires Weight Loss Down Through The Generations
27 nov. 2019 08h00 HE
|
123 Diet
BOCA RATON, FL, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Mazz Sturgeon knew she needed to lose weight. According to her, she has struggled with emotional eating since she was in her twenties, and though...
Obalon To Present at Two Upcoming Institutional Investor Conferences
14 nov. 2019 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and...
Obalon Announces Third Quarter 2019 Financial Results
08 nov. 2019 07h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Clinical Data Set to be Featured During the 36th ASMBS Annual Meeting at Obesity Week 2019
05 nov. 2019 05h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Stay Healthy With The 123 Diet This Halloween!
31 oct. 2019 09h01 HE
|
123 Diet
Boca Raton, Fl., Oct. 31, 2019 (GLOBE NEWSWIRE) -- If you've been watching your waistline, you may, understandably, be feeling a little frustrated this Halloween season. It’s a feeling that Emma...
Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time
31 oct. 2019 07h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...